China Greenlights Imports of Two New GMO Products
China has approved imports of two new varieties of genetically modified crops, drawing praise from U.S. industry representatives who have sought to pry open more access to its vast agricultural market.
The decision, announced Wednesday, will allow U.S. giants Dow Chemical Co. and Monsanto Co. to export genetically altered corn and soybean varieties to China, and comes after Beijing agreed to speed up reviews of biotechnology applications as part of a trade deal with the Trump administration last month.
China's Ministry of Agriculture said imports of the new products could begin this week. Specifically, the ministry approved imports of Dow AgroSciences' Enlist corn variety and Monsanto's Vistive Gold soybean.
In addition, 14 other genetically modified crop varieties were renewed for importing into China.
The decision "is a positive step," said Zhang Xiaoping, China representative for the U.S. Soybean Export Council.
China's decision to allow new imports of genetically modified crops comes as the government struggles to balance a desire to boost farms' productivity with a deep mistrust of such crops by its citizens.
There is a general scientific consensus in the U.S. that GMO crops are safe. But in China, doubts remain. While the government has said it believes genetically modified crops are safe in principle, it has been cautious about approving new varieties for imports, fearing a public backlash.
Unlike in the U.S., China doesn't permit planting of genetically modified seeds for staple grains such as corn and soybeans. Loosening those restriction is one measure that would help boost yields at Chinese farms, say industry executives, a huge goal for China's government as it strives to feed its growing middle class.
State-owned China National Chemical Corp.'s recent deal to buy Switzerland's Syngenta AG -- a major developer of genetically modified seeds -- brought such issues to the forefront of a public dialogue over genetically altered crops in China. Many foreign executives hope such a deal by a major Chinese state-owned enterprise could help open the market for more genetically modified crops over time.
The U.S. Commerce Department said in May that eight U.S. biotechnology applications were pending in China. DuPont Co. says while it has yet to receive approval for an insect-control trait for corn it is seeking in China, it was "encouraged by the fast progress" of China's government in the latest approvals, and looked forward to the approval of additional products.
Looking for chemical products? Let suppliers reach out to you!
2026-09-08
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
South Korea to Impose Anti-Dumping Duties on Caustic Soda: Chinese Mainland Firms Face Up to 22.21%, Taiwan Region 38.89%
-
EAEU Initiates Review of Anti-Dumping Measures on Chinese Titanium Dioxide, Suspends Duties During Investigation
-
Three Major Indian Chemical Investments Target China's PC Exports
-
Pakistan Launches Successive Anti-dumping Investigations against Chinese Products, Involving Soda Ash, Ibuprofen and Other Raw Materials
-
South Korea Initiates Anti-Dumping Probe on Chinese PVC Suspension Resin, Involving Tianjin Bohua and Wanhua Chemical
-
China Keeps Registering Pesticides
-
India Launches Anti-Dumping Probe into PET Film from China, Singapore, Thailand and the UAE
-
INEOS Warns Chinese Chemical “Dumping” Is Hitting Europe’s Industry
-
Covestro Builds New 660,000-ton MDI Plant in China: Global Supply Gap Meets Chinese Overcapacity Head-On
-
India Imposes Final Anti‑Dumping Duties on Ethylenediamine from China, EU, Saudi Arabia, and Taiwan, China, with Top Rate of $575/tonne
Recommend Reading
-
The 93rd API China
-
The 94th API China
-
2025 ECHEMI Global Buyer Match Event
-
July Palm Oil Market Oscillates and Rises in China
-
International Oil Prices Experience a "Heart-Stopping Day" as U.S.-Iran Tensions Trigger Massive Shockwaves in the Energy Market
-
Coke market mainly maintains stable operation with overall balanced supply and demand in China
-
China NMPA Issues Priority Review Pathway for Four Categories of Chemical Active Pharmaceutical Ingredients, Effective August 1, 2026
-
July Domestic Refinery Petcoke Prices First Rise Then Fall